-
Mashup Score: 28UnitedHealth to wind down Optum telehealth business - report - 18 day(s) ago
UnitedHealth Group is shutting down its Optum Virtual Care telehealth business. Read more here.
Source: seekingalpha.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 24
Drugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the next five years, according to a new report by Global Data. Read more here.
Source: seekingalpha.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11
The U.S. FDA grants orphan drug designation to BeiGene’s sonrotoclax for relapsed/refractory multiple myeloma treatment.
Source: seekingalpha.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Crispr Therapeutics Is Overvalued (Rating Downgrade) (NASDAQ:CRSP) - 4 month(s) ago
Casgevy’s gene-editing approval for SCD is hindered by high costs, a limited market, intense competition, and safety concerns, making CRSP overvalued. Read more.
Source: seekingalpha.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1BrainStorm Cell stock spikes on patent wins (NASDAQ:BCLI) - 5 month(s) ago
Shares of biotech Brainstorm Cell Therapeutics (BCLI) surged 29% as the company secured multiple patents internationally. Read more here.
Source: seekingalpha.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0
QuidelOrtho (QDEL) has received FDA clearance for its Savanna PCR platform and test panel for Herpes simplex virus type 1 and 2 and Varicella-zoster virus. Read more here.
Source: seekingalpha.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1
Start Time: 08:30 January 1, 0000 8:58 AM ETBrainStorm Cell Therapeutics Inc.
Source: seekingalpha.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 42Eli Lilly stock gains on FDA nod for obesity drug (NYSE:LLY) - 6 month(s) ago
The U.S. FDA has approved Eli Lilly’s weight loss treatment, Zepbound, providing competition in the obesity drug market dominated by Novo Nordisk (NVO). Read more here.
Source: seekingalpha.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3Global telemedicine market to hit $450B in 2032 - 6 month(s) ago
The global telemedicine market is set to reach $450B by 2032, growing at a compound annual growth rate of 18%, according to a recent industry report. Read more here.
Source: seekingalpha.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
BrainStorm Cell Therapeutics announces strategic realignment to support accelerated development of NurOwn for ALS treatment, including a Phase 3b clinical…
Source: seekingalpha.comCategories: General Medicine News, Rare DiseaseTweet
What are people's smart takes on Optum getting out of the telehealth biz? Confirmed yesterday. https://t.co/3Wj1RnyzxC